SCHEMBL8547731

SCHEMBL8547731

COCc1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(Br)cc2)o1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.50
PTGS1 P23219 3/20 0.50
CA2 P00918 11/20 0.47
CA9 Q16790 9/20 0.47
CA12 O43570 7/20 0.47
CA1 P00915 8/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
NPY1R P25929 1/20 0.43
NPY2R P49146 1/20 0.43
CA7 P43166 2/20 0.41
CA4 P22748 3/20 0.39
CA5A P35218 1/20 0.38
CA5B Q9Y2D0 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8148477 0.89 PTGS2 (0.51) PTGS2PTGS1CA2CA9CA12
SCHEMBL8552103 0.89 PTGS2 (0.51) PTGS2PTGS1CA2CA9CA12
SCHEMBL8552170 0.88 PTGS2 (0.50) PTGS2PTGS1CA2CA9CA12
SCHEMBL8546102 0.88 PTGS2 (0.66) PTGS2PTGS1CA2CA9CA12
SCHEMBL8547060 0.88 PTGS2 (0.50) PTGS2PTGS1CA2CA9CA12
SCHEMBL8552080 0.81 CA2 (0.52) PTGS2PTGS1CA2CA9CA12
SCHEMBL8552563 0.81 CA2 (0.52) PTGS2PTGS1CA2CA9CA12
SCHEMBL8140711 0.80 PTGS2 (0.76) PTGS2PTGS1CA2CA9CA12
SCHEMBL8552366 0.80 PTGS2 (0.76) PTGS2PTGS1CA2CA9CA12
SCHEMBL7502659 0.76 CA1 (0.56) PTGS2PTGS1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP claimed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO claimed
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO disclosed